Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Medicinas Complementares
Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ann Rheum Dis ; 62(9): 880-4, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12922963

RESUMO

BACKGROUND: The value of antibiotics in the treatment of reactive arthritis (ReA) is still controversial. OBJECTIVES: To analyse the long term outcome of patients with ReA, treated with a three month course of ciprofloxacin or placebo. METHODS: Patients who had had ReA and had participated in a double blind, placebo controlled trial on the effectiveness of ciprofloxacin 4-7 years earlier were invited to a clinical examination. Of the 71 patients who were included in the original study, 53 agreed to visit the clinic for an examination. Twenty six of 53 patients had originally received ciprofloxacin and 27 had belonged to the placebo group. Of these, 20 in the ciprofloxacin and 25 in the placebo group were HLA-B27 positive. RESULTS: 11/27 (41%) patients in the original placebo group had now developed chronic rheumatic disease, as compared with only 2/26 (8%) patients originally treated with ciprofloxacin (p=0.006). Two patients who originally had received placebo, none in the ciprofloxacin group had developed ankylosing spondylitis, and three patients in the original placebo group, none in the ciprofloxacin group had recurrent anterior uveitis. The same tendency was seen when several different measures were analysed. Of the patients with chronic spondyloarthropathy, 10 in the placebo and none in the ciprofloxacin group were HLA-B27 positive. CONCLUSION: Analysis 4-7 years after the initial ReA suggests that a three month course of antibiotics in the acute phase may have a beneficial effect on the long term prognosis.


Assuntos
Anti-Infecciosos/uso terapêutico , Artrite Reativa/tratamento farmacológico , Ciprofloxacina/uso terapêutico , Doença Aguda , Adulto , Idoso , Doença Crônica , Método Duplo-Cego , Esquema de Medicação , Feminino , Seguimentos , Antígeno HLA-B27/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Proibitinas , Doenças Reumáticas/imunologia , Doenças Reumáticas/prevenção & controle , Resultado do Tratamento
3.
Ann Rheum Dis ; 58(9): 559-62, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10460189

RESUMO

OBJECTIVES: To assess the predictive significance of synovial fluid (SF) analysis for progressive radiological knee joint destruction in arthritis. METHODS: Altogether 55 patients with arthritis and knee joint effusion were included in the study. The diagnosis was rheumatoid arthritis (RA) for 44 of them, chronic seronegative spondylarthropathy for seven and juvenile rheumatoid arthritis for four. The mean age of the patients was 51.8 (SD 14.9, range 19-82) years, and the mean duration of disease 10.9 (SD 9.2, range 0.5-37) years. In addition to the routine laboratory tests, different markers of collagen synthesis and breakdown in serum and SF were assessed. The radiological grade of the knee joint was assessed by Larsen's method at the baseline and after a three year follow up. RESULTS: During the follow up, Larsen's grade deteriorated in 22 (40%) patients. These patients had a significantly higher median level of cross linked carboxyterminal telopeptide of type I collagen (ICTP) in SF at entry than those who had a stable index (p = 0.035). Serum ICTP did not have any predictive value for a specific joint. The median levels of total SF leucocytes (p = 0.012) and the subgroup of polymorphonuclear leucocytes (p = 0.018) were higher in the patients with a stable Larsen's index. However, the relation of SF leucocyte level to radiological progression could not be confirmed in the RA group. CONCLUSION: It is concluded that SF analysis may help in the identification of patients with inflammatory arthritis who are at risk for progressive destruction in a particular joint. A high total SF leucocyte level is not necessarily associated with a poor prognosis. Instead, a high SF ICTP level seems to reflect accelerated bone degradation.


Assuntos
Artrite/metabolismo , Colágeno/metabolismo , Articulação do Joelho/metabolismo , Líquido Sinovial/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Artrite/diagnóstico por imagem , Artrite Reumatoide/metabolismo , Biomarcadores/análise , Colágeno Tipo I , Progressão da Doença , Seguimentos , Humanos , Contagem de Leucócitos , Pessoa de Meia-Idade , Peptídeos/metabolismo , Radiografia , Índice de Gravidade de Doença
4.
Clin Exp Rheumatol ; 11(3): 301-7, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8353985

RESUMO

In a double-blind study comprising 36 patients the effect of a three-month course of ciprofloxacin on chronic reactive arthritis was evaluated. At the end of the follow-up period 6 months after stopping the therapy, arthralgia, pain at movement and morning stiffness had decreased significantly compared to the values before the treatment in the ciprofloxacin group, whereas the Ritchie index and ESR showed a significant decrease in the control group. We conclude that further studies are necessary before the value of prolonged ciprofloxacin treatment of chronic reactive arthritis can be established.


Assuntos
Antibacterianos/uso terapêutico , Artrite Reativa/tratamento farmacológico , Infecções por Campylobacter/tratamento farmacológico , Ciprofloxacina/uso terapêutico , Yersiniose/tratamento farmacológico , Adulto , Artrite Reativa/fisiopatologia , Sedimentação Sanguínea , Campylobacter jejuni , Doença Crônica , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Yersiniose/fisiopatologia
5.
Clin Exp Rheumatol ; 5(4): 343-8, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-2449987

RESUMO

Factor analysis was used in clarifying the picture of joint inflammation. 376 arthritis patients were examined at the onset of the disease and after three years. The six factors produced are interpreted to represent six components of joint inflammation, namely the anaemic factor, the factors of clinical joint inflammation gammaglobulin activity, complement activity and acute phase, and the factor of alfa-beta globulin activity. The factor structure remained quite similar during the follow-up. This would indicate that there are certain basic aspects of inflammation which remain fairly stable from year to year.


Assuntos
Artrite/metabolismo , Adulto , Anemia/sangue , Artrite/patologia , Proteínas do Sistema Complemento/metabolismo , Análise Fatorial , Feminino , Humanos , Articulações/patologia , Masculino , Soroglobulinas/metabolismo , gama-Globulinas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA